Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bo Baldetorp

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Physiology

Anatomy

Aneuploidy

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
47
Fernö, Mårten
27
Killander, Dick
21
Borg, Ake
13
Olsson, Håkan
12
Akerman, Måns
11
Bendahl, Pär-Ola
10
Wennerberg, Johan
9
Willén, Helena
8
Rydholm, Anders
7
Gustafson, Pelle
7
Oredsson, Stina
6
Mertens, Fredrik
6
Mandahl, Nils
6
Heim, Sverre
6
Isola, Jorma

Sign-in to see all Coauthors

Publications

TOP 3
Welinder Charlotte; Jansson Bo; Ferno Marten; Olson Hakan; Baldetorp Bo
Expression of Helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes.
Odenlund M; Holmqvist B; Baldetorp B; Hellstrand P; Nilsson Bengt-Olof
Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.
Henriksson Eva; Kjellén Elisabeth; Baldetorp Bo; Bendahl Pär-Ola; Borg Ake; Brun Eva; Mertens Fredrik; Ohlsson Tomas; Rennstam Karin; Wennerberg Johan; Wahlberg Peter
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bo Baldetorp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Welinder Charlotte; Jansson Bo; Ferno Marten; Olson Hakan; Baldetorp Bo
Expression of Helix pomatia lectin binding glycoproteins in women with breast cancer in relationship to their blood group phenotypes.
Journal of proteome research 2009;8(2):782-7.
2009: Odenlund M; Holmqvist B; Baldetorp B; Hellstrand P; Nilsson Bengt-Olof
Polyamine synthesis inhibition induces S phase cell cycle arrest in vascular smooth muscle cells.
Amino acids 2009;36(2):273-82.
2009: Henriksson Eva; Kjellén Elisabeth; Baldetorp Bo; Bendahl Pär-Ola; Borg Ake; Brun Eva; Mertens Fredrik; Ohlsson Tomas; Rennstam Karin; Wennerberg Johan; Wahlberg Peter
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck.
Journal of experimental & clinical cancer research : CR 2009;28():17.
2007: Sköld Martin; Rydén Tobias; Samuelsson Viktoria; Bratt Charlotte; Ekblad Lars; Olsson Håkan; Baldetorp Bo
Regression analysis and modelling of data acquisition for SELDI-TOF mass spectrometry.
Bioinformatics (Oxford, England) 2007;23(11):1401-9.
2007: Feridani Amir H Iranpour; Holmqvist Bo; Sjögren Hans-Olov; Strand Sven-Erik; Tennvall Jan; Baldetorp Bo
Combined flow cytometry and confocal laser scanning microscopy for evaluation of BR96 antibody cancer cell targeting and internalization.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2007;71(6):361-70.
2007: Ekblad Lars; Baldetorp Bo; Fernö Mårten; Olsson Håkan; Bratt Charlotte
In-source decay causes artifacts in SELDI-TOF MS spectra.
Journal of proteome research 2007;6(4):1609-14.
2007: Rennstam Karin; Jönsson Göran; Tanner Minna; Bendahl Pär-Ola; Staaf Johan; Kapanen Anita I; Karhu Ritva; Baldetorp Bo; Borg Ake; Isola Jorma
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
Cancer genetics and cytogenetics 2007;172(2):95-106.
2006: Henriksson Eva; Baldetorp Bo; Borg Ake; Kjellen Elisabeth; Akervall Jan; Wennerberg Johan; Wahlberg Peter
p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
Acta oncologica (Stockholm, Sweden) 2006;45(3):300-5.
2004: Brun Eva; Tennvall Jan; Baldetorp Bo; Kjellén Elisabeth; Fallenius Ghita; Wennerberg Johan
DNA ploidy, S-phase fraction and associations with 2-18F-fluoro-deoxy-2-D-glucose positron emission tomography findings before and during therapy of head and neck squamous cell carcinoma.
Acta oto-laryngologica 2004;124(6):712-9.
2004: Niméus Emma; Baldetorp Bo; Bendahl Pär-Ola; Rennstam Karin; Wennerberg Johan; Akervall Jan; Fernö Mårten
Amplification of the cyclin D1 gene is associated with tumour subsite, DNA non-diploidy and high S-phase fraction in squamous cell carcinoma of the head and neck.
Oral oncology 2004;40(6):624-9.
2004: Hogberg T; Fredstorp-Lidebring M; Alm P; Baldetorp B; Larsson G; Ottosen C; Svanberg L; Lindahl B;
A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endometrial cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2004;14(3):437-50.
2004: Håkansson P; Lassen C; Olofsson T; Baldetorp B; Karlsson A; Gullberg U; Fioretos T
Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(3):538-47.
2004: Gruvberger-Saal Sofia K; Edén Patrik; Ringnér Markus; Baldetorp Bo; Chebil Gunilla; Borg Ake; Fernö Mårten; Peterson Carsten; Meltzer Paul S
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
Molecular cancer therapeutics 2004;3(2):161-8.
2003: Rennstam Karin; Ahlstedt-Soini Minna; Baldetorp Bo; Bendahl Pär-Ola; Borg Ake; Karhu Ritva; Tanner Minna; Tirkkonen Mika; Isola Jorma
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
Cancer research 2003;63(24):8861-8.
2003: Adeyinka Adewale; Baldetorp Bo; Mertens Fredrik; Olsson Håkan; Johannsson Oskar; Heim Sverre; Pandis Nikos
Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas.
Cancer genetics and cytogenetics 2003;147(1):62-7.
2003: Baldetorp Bo; Bendahl Pär-Ola; Fernö Mårten; Stål Olle
Improved DNA flow cytometric, DNA ploidy, and S-phase reproducibility between 15 laboratories in analysis of breast cancer using generalized guidelines.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2003;56(1):1-7.
2003: Rudolph Pierre; Kühling Heidi; Alm Per; Fernö Mårten; Baldetorp Bo; Olsson Håkan; Parwaresch Reza
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancer.
International journal of cancer. Journal international du cancer 2003;105(5):674-80.
2003: Olsson H; Baldetorp B; Fernö M; Perfekt R
Relation between the rate of tumour cell proliferation and latency time in radiation associated breast cancer.
BMC cancer 2003;3():11.
2003: Kühling Heidi; Alm Per; Olsson Håkan; Fernö Mårten; Baldetorp Bo; Parwaresch Reza; Rudolph Pierre
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancer.
The Journal of pathology 2003;199(4):424-31.
2003: Johannsson Oskar T; Staff Synnöve; Vallon-Christersson Johan; Kytöla Soili; Gudjonsson Thorarinn; Rennstam Karin; Hedenfalk Ingrid A; Adeyinka Adewale; Kjellén Elisabeth; Wennerberg Johan; Baldetorp Bo; Petersen Ole W; Olsson Håkan; Oredsson Stina; Isola Jorma; Borg Ake
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier.
Laboratory investigation; a journal of technical methods and pathology 2003;83(3):387-96.
2002: Fernebro Eva; Halvarsson Britta; Baldetorp Bo; Nilbert Mef
Predominance of CIN versus MSI in the development of rectal cancer at young age.
BMC cancer 2002;2():25.
2002: Planck Maria; Halvarsson Britta; Pålsson Eva; Hallén Magnus; Ekelund Mats; Pålsson Birger; Baldetorp Bo; Nilbert Mef
Cytogenetic aberrations and heterogeneity of mutations in repeat-containing genes in a colon carcinoma from a patient with hereditary nonpolyposis colorectal cancer.
Cancer genetics and cytogenetics 2002;134(1):46-54.
2002: Dreinhöfer Karsten E; Baldetorp Bo; Akerman Måns; Fernö Mårten; Rydholm Anders; Gustafson Pelle
DNA ploidy in soft tissue sarcoma: comparison of flow and image cytometry with clinical follow-up in 93 patients.
Cytometry 2002;50(1):19-24.
2002: Mandahl Nils; Gustafson Pelle; Mertens Fredrik; Akerman Måns; Baldetorp Bo; Gisselsson David; Knuutila Sakari; Bauer Henrik C F; Larsson Olle
Cytogenetic aberrations and their prognostic impact in chondrosarcoma.
Genes, chromosomes & cancer 2002;33(2):188-200.
2002: Hou Mingyan; Harden T Kendall; Kuhn Cynthia M; Baldetorp Bo; Lazarowski Eduardo; Pendergast William; Möller Sebastian; Edvinsson Lars; Erlinge David
UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors.
American journal of physiology. Heart and circulatory physiology 2002;282(2):H784-92.
2001: Bagwell C B; Clark G M; Spyratos F; Chassevent A; Bendahl P O; Stål O; Killander D; Jourdan M L; Romain S; Hunsberger B; Wright S; Baldetorp B
DNA and cell cycle analysis as prognostic indicators in breast tumors revisited.
Clinics in laboratory medicine 2001;21(4):875-95, x.
2001: Bagwell C B; Clark G M; Spyratos F; Chassevent A; Bendahl P O; Stål O; Killander D; Jourdan M L; Romain S; Hunsberger B; Baldetorp B
Optimizing flow cytometric DNA ploidy and S-phase fraction as independent prognostic markers for node-negative breast cancer specimens.
Cytometry 2001;46(3):121-35.
2001: Rudolph P; Alm P; Olsson H; Heidebrecht H J; Fernö M; Baldetorp B; Parwaresch R
Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
Human pathology 2001;32(3):311-9.
2001: Rennstam K; Baldetorp B; Kytölä S; Tanner M; Isola J
Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer.
Cancer research 2001;61(3):1214-9.
2000: Adeyinka A; Mertens F; Bondeson L; Garne J P; Borg A; Baldetorp B; Pandis N
Cytogenetic heterogeneity and clonal evolution in synchronous bilateral breast carcinomas and their lymph node metastases from a male patient without any detectable BRCA2 germline mutation.
Cancer genetics and cytogenetics 2000;118(1):42-7.
2000: Fernö M; Stål O; Baldetorp B; Hatschek T; Källström A C; Malmström P; Nordenskjöld B; Rydën S
Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels. South Sweden Breast Cancer Group, and South-East Sweden Breast Cancer Group.
Breast cancer research and treatment 2000;59(1):69-76.
1999: Persson K; Pandis N; Mertens F; Borg A; Baldetorp B; Killander D; Isola J
Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization.
Genes, chromosomes & cancer 1999;25(2):115-22.
1999: Gustafson P; Baldetorp B; Fernö M; Akerman M
Prognostic implications of various models for calculation of S-phase fraction in 259 patients with soft tissue sarcoma.
British journal of cancer 1999;79(7-8):1205-9.
1999: Rudolph P; Alm P; Heidebrecht H J; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Journal of the National Cancer Institute 1999;91(3):271-8.
1999: Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
The Journal of pathology 1999;187(2):207-16.
1999: Johansson M C; Baldetorp B; Oredsson S M
Energy transfer between fluorescein isothiocyanate and propidium iodide--a problem in the estimation of Tpot with the bromodeoxyuridine-DNA flow cytometry technique?
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1999;19(2):91-8.
1998: Stål O; Baldetorp B
S-phase fraction assessed by a variant of the rectangular model adapted to the flow-cytometric DNA histogram profile.
Cytometry 1998;33(4):487-91.
1998: Baldetorp B; Stål O; Ahrens O; Cornelisse C; Corver W; Falkmer U; Fernö M
Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group.
Cytometry 1998;33(4):385-93.
1998: Ehinger M; Bergh G; Johnsson E; Baldetorp B; Olsson I; Gullberg U
p53-dependent and -independent differentiation of leukemic U-937 cells: relationship to cell cycle control.
Experimental hematology 1998;26(11):1043-52.
1998: Johansson M C; Johansson R; Baldetorp B; Oredsson S M
Comparison of different labelling index formulae used on bromodeoxyuridine-flow cytometry data.
Cytometry 1998;32(3):233-40.
1998: Tanner M M; Karhu R A; Nupponen N N; Borg A; Baldetorp B; Pejovic T; Fernö M; Killander D; Isola J J
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene.
The American journal of pathology 1998;153(1):191-9.
1998: Baldetorp B; Fernö M; Bendahl P O; Fallenius G; Idvall I; Akerman M; Killander D
Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1998;20(2):144-52.
1998: Akervall J; Jin Y; Baldetorp B; Mertens F; Wennerberg J
Complex karyotypes in flow cytometrically DNA-diploid squamous cell carcinomas of the head and neck.
British journal of cancer 1998;77(7):1082-8.
1998: Svedberg H; Chylicki K; Baldetorp B; Rauscher F J; Gullberg U
Constitutive expression of the Wilms' tumor gene (WT1) in the leukemic cell line U937 blocks parts of the differentiation program.
Oncogene 1998;16(7):925-32.
1998: Wennerberg J; Baldetorp B; Wahlberg P
Distribution of non-diploid flow-cytometric DNA indices and their relation to the nodal metastasis in squamous cell carcinomas of the head and neck.
Invasion & metastasis 1998;18(4):184-91.
1997: Hedenfalk I A; Baldetorp B; Borg A; Oredsson S M
Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry.
Cytometry 1997;29(4):321-7.
1997: Bergh G; Ehinger M; Olofsson T; Baldetorp B; Johnsson E; Brycke H; Lindgren G; Olsson I; Gullberg U
Altered expression of the retinoblastoma tumor-suppressor gene in leukemic cell lines inhibits induction of differentiation but not G1-accumulation.
Blood 1997;89(8):2938-50.
1997: Gustafson P; Fernö M; Akerman M; Baldetorp B; Willén H; Killander D; Rydholm A
Flow cytometric S-phase fraction in soft-tissue sarcoma: prognostic importance analysed in 160 patients.
British journal of cancer 1997;75(1):94-100.
1996: Wennerberg J; Baldetorp B; Wahlberg P; Zätterström U K
Flow cytometry analysis of malignant tumors of the head and neck--differences between two methods in the recognition of aneuploidy.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1996;12(3):125-36.
1996: Johansson M C; Baldetorp B; Bendahl P O; Fadeel I A; Oredsson S M
Comparison of mathematical formulas used for estimation of DNA synthesis time of bromodeoxyuridine-labelled cell populations with different proliferative characteristics.
Cell proliferation 1996;29(10):525-38.
1996: Bratt O; Anderson H; Bak-Jensen E; Baldetorp B; Lundgren R
Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis.
Urology 1996;47(2):218-24.
1996: Ehinger M; Bergh G; Olofsson T; Baldetorp B; Olsson I; Gullberg U
Expression of the p53 tumor suppressor gene induces differentiation and promotes induction of differentiation by 1,25-dihydroxycholecalciferol in leukemic U-937 cells.
Blood 1996;87(3):1064-74.
1996: Fernö M; Baldetorp B; Fallenius G; Idvall I; Johansson U; Killander D
Preoperative fine needle aspiration from human breast cancer is a valuable sampling material for progesterone receptor and cytometric DNA analysis.
Acta oncologica (Stockholm, Sweden) 1996;35 Suppl 8():19-25.
1996: Gudmundsson T E; Långström E; Alm P; Anderson H; Baldetorp B; Fernö M; Högberg T; Killander D
Methodological aspects of flow cytometry DNA analysis in endometrial carcinoma, with special reference to sampling and reproducibility.
Acta oncologica (Stockholm, Sweden) 1996;35(8):999-1006.
1995: Baldetorp B; Bendahl P O; Fernö M; Alanen K; Delle U; Falkmer U; Hansson-Aggesjö B; Höckenström T; Lindgren A; Mossberg L
Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates.
Cytometry 1995;22(2):115-27.
1995: Fernö M; Baldetorp B; Bendahl P O; Borg A; Ewers S B; Olsson H; Rydén S; Sigurdsson H; Killander D
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.
Breast cancer research and treatment 1995;36(1):23-34.
1995: Gudmundsson T E; Högberg T; Alm P; Anderson H; Baldetorp B; Fernö M; Långström E; Killander D
The prognostic information of DNA ploidy and S-phase fraction may vary with histologic grade in endometrial carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(6):803-12.
1994: Choong P F; Akerman M; Willén H; Andersson C; Gustafson P; Baldetorp B; Fernö M; Alvegård T; Rydholm A
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(12):915-24.
1994: Borg A; Baldetorp B; Fernö M; Killander D; Olsson H; Rydén S; Sigurdsson H
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer.
Cancer letters 1994;81(2):137-44.
1994: Fredlund J O; Johansson M; Baldetorp B; Oredsson S M
Abnormal DNA synthesis in polyamine deficient cells revealed by bromodeoxyuridine-flow cytometry technique.
Cell proliferation 1994;27(5):243-56.
1994: Fernö M; Baldetorp B; Borg A; Brouillet J P; Olsson H; Rochefort H; Sellberg G; Sigurdsson H; Killander D
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2042-8.
1993: Horvath G; Fernö M; Baldetorp B; Johansson M
Growth interaction between different tumor populations in human endometrial adenocarcinoma growing in nude mice.
In vivo (Athens, Greece) 1993;7(6A):511-7.
1993: Gustafson P; Rydholm A; Willén H; Baldetorp B; Fernö M; Akerman M
Liposarcoma: a population-based epidemiologic and prognostic study of features of 43 patients, including tumor DNA content.
International journal of cancer. Journal international du cancer 1993;55(4):541-6.
1993: Horvath G; Baldetorp B; Fernö M; Johansson M; Nesland J; Tropé C
Effect of estradiol on tumor growth, cell kinetics and p53 oncoprotein expression in human endometrial adenocarcinoma heterotransplanted into nude mice.
In vivo (Athens, Greece) 1993;7(5):451-6.
1993: Mertens F; Mandahl N; Orndal C; Baldetorp B; Bauer H C; Rydholm A; Wiebe T; Willén H; Akerman M; Heim S
Cytogenetic findings in 33 osteosarcomas.
International journal of cancer. Journal international du cancer 1993;55(1):44-50.
1993: Tennvall J; Wennerberg J; Anderson H; Baldetorp B; Fernö M; Willén R
DNA analysis as a predictor of the outcome of induction chemotherapy in advanced head and neck carcinomas.
Archives of otolaryngology--head & neck surgery 1993;119(8):867-70.
1993: Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
Anticancer research 1993;13(4):1187-96.
1993: Mandahl N; Baldetorp B; Fernö M; Akerman M; Rydholm A; Heim S; Willén H; Killander D; Mitelman F
Comparative cytogenetic and DNA flow cytometric analysis of 150 bone and soft-tissue tumors.
International journal of cancer. Journal international du cancer 1993;53(3):358-64.
1992: Borg A; Baldetorp B; Fernö M; Olsson H; Sigurdsson H
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer.
International journal of cancer. Journal international du cancer 1992;51(5):687-91.
1992: Gustafson P; Willén H; Baldetorp B; Fernö M; Akerman M; Rydholm A
Soft tissue leiomyosarcoma. A population-based epidemiologic and prognostic study of 48 patients, including cellular DNA content.
Cancer 1992;70(1):114-9.
1992: Ewers S B; Attewell R; Baldetorp B; Borg A; Långström E; Killander D
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas.
Breast cancer research and treatment 1992;20(2):93-108.
1992: Pejovic T; Heim S; Mandahl N; Baldetorp B; Elmfors B; Flodérus U M; Furgyik S; Helm G; Himmelmann A; Willén H
Chromosome aberrations in 35 primary ovarian carcinomas.
Genes, chromosomes & cancer 1992;4(1):58-68.
1992: Ewers S B; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Killander D
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study.
Breast cancer research and treatment 1992;24(2):115-26.
1992: Fernö M; Baldetorp B; Borg A; Olsson H; Sigurdsson H; Killander D
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome.
Acta oncologica (Stockholm, Sweden) 1992;31(2):157-65.
1992: Fernö M; Baldetorp B; Ewers S B; Idvall I; Olsson H; Sigurdsson H; Killander D
One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?
Cytometry 1992;13(3):241-9.
1992: Ewers S B; Attewell R; Baldetorp B; Borg A; Fernö M; Långström E; Rydén S; Killander D
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer.
Acta oncologica (Stockholm, Sweden) 1992;31(7):733-40.
1992: Zätterström U K; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Cytometry 1992;13(8):872-9.
1992: Baldetorp B; Fernö M; Fallenius A; Fallenius-Vecchi G; Idvall I; Olsson H; Sigurdsson H; Akerman M; Killander D
Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry.
Cytometry 1992;13(6):577-85.
1991: Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
Estradiol induced changes in tumor growth and steroid receptor content in a heterotransplanted human endometrial adenocarcinoma.
In vivo (Athens, Greece) 1991;5(4):401-6.
1991: Dictor M; Fernö M; Baldetorp B
Flow cytometric DNA content in Kaposi's sarcoma by histologic stage. Comparison with angiosarcoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1991;13(3):201-8.
1991: Olsson H; Ranstam J; Baldetorp B; Ewers S B; Fernö M; Killander D; Sigurdsson H
Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortions.
Cancer 1991;67(5):1285-90.
1991: Horvath G; Fernö M; Baldetorp B; Cameron R; Ranstam J
Progression of human endometrial adenocarcinoma heterotransplanted into nude mice from hormone-sensitive to hormone resistant growth.
In vivo (Athens, Greece) 1991;5(2):185-90.
1991: Borg A; Baldetorp B; Fernö M; Killander D; Olsson H; Sigurdsson H
ERBB2 amplification in breast cancer with a high rate of proliferation.
Oncogene 1991;6(1):137-43.
1990: Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M; Killander D; Olsson H; Ranstam J
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels.
British journal of cancer 1990;62(5):786-90.
1990: Nilbert M; Mandahl N; Heim S; Rydholm A; Helm G; Willén H; Baldetorp B; Mitelman F
Complex karyotypic changes, including rearrangements of 12q13 and 14q24, in two leiomyosarcomas.
Cancer genetics and cytogenetics 1990;48(2):217-23.
1990: Fernö M; Baldetorp B; Akerman M
Flow cytometric DNA ploidy analysis of soft tissue sarcomas. A comparative study of preoperative fine needle aspirates and postoperative fresh tissues and archival material.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1990;12(4):251-8.
1990: Fernö M; Långström-Einarsson E; Willén R; Baldetorp B; Killander D
Improved preparation technique of cervical carcinoma for flow cytometric DNA analysis with tissue disintegration in hydrochloric acid.
In vivo (Athens, Greece) 1990;4(4):225-9.
1990: Sigurdsson H; Baldetorp B; Borg A; Dalberg M; Fernö M; Killander D; Olsson H
Indicators of prognosis in node-negative breast cancer.
The New England journal of medicine 1990;322(15):1045-53.
1989: Baldetorp B; Dalberg M; Holst U; Lindgren G
Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm.
Cytometry 1989;10(6):695-705.
1989: Nilbert M; Heim S; Mandahl N; Flodérus U M; Willén H; Baldetorp B; Mitelman F
Complex karyotypic anomalies in a bizarre leiomyoma of the uterus.
Genes, chromosomes & cancer 1989;1(2):131-4.
1989: Ewers S B; Baldetorp B; Killander D; Långström E
Flow cytometry DNA ploidy and number of cell populations in the primary breast cancer and their correlation to the prognosis.
Acta oncologica (Stockholm, Sweden) 1989;28(6):913-8.
1985: Linden M; Anehus S; Långström E; Baldetorp B; Heby O
Cell cycle phase-dependent induction of ornithine decarboxylase-antizyme.
Journal of cellular physiology 1985;125(2):273-6.
1984: Ewers S B; Långström E; Baldetorp B; Killander D
Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
Cytometry 1984;5(4):408-19.
1984: Anehus S; Pohjanpelto P; Baldetorp B; Långström E; Heby O
Polyamine starvation prolongs the S and G2 phases of polyamine-dependent (arginase-deficient) CHO cells.
Molecular and cellular biology 1984;4(5):915-22.

Sign-in to see more